These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


96 related items for PubMed ID: 12740668

  • 1. Functional outcome and subset identification in RA patients from meridional Europe: analysis of a Spanish cohort.
    Calvo-Alén J, Corrales A, Sánchez-Andrada S, Fernández-Echevarría MA, Peña JL, Rodriguez-Valverde V.
    Clin Rheumatol; 2003 May; 22(2):77-83. PubMed ID: 12740668
    [Abstract] [Full Text] [Related]

  • 2. Outcome of late-onset rheumatoid arthritis.
    Calvo-Alén J, Corrales A, Sánchez-Andrada S, Fernández-Echevarría MA, Peña JL, Rodríguez-Valverde V.
    Clin Rheumatol; 2005 Sep; 24(5):485-9. PubMed ID: 15750680
    [Abstract] [Full Text] [Related]

  • 3. High dose chemotherapy and hematopoietic stem cell transplantation: a study of treatment preference in patients with rheumatoid arthritis and rheumatologists.
    Verburg RJ, Mahabali SD, Stiggelbout AM, Sont JK, van Laar JM.
    J Rheumatol; 2002 Aug; 29(8):1653-8. PubMed ID: 12180724
    [Abstract] [Full Text] [Related]

  • 4. Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis.
    Welsing PM, Fransen J, van Riel PL.
    Arthritis Rheum; 2005 Sep; 52(9):2616-24. PubMed ID: 16142762
    [Abstract] [Full Text] [Related]

  • 5. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.
    Quinn MA, Conaghan PG, O'Connor PJ, Karim Z, Greenstein A, Brown A, Brown C, Fraser A, Jarret S, Emery P.
    Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102
    [Abstract] [Full Text] [Related]

  • 6. Rheumatoid factor by laser nephelometry and Waaler-Rose assay: prognostic value in patients with recent-onset rheumatoid arthritis.
    Nikolaisen C, Rekvig OP, Nossent HC.
    Scand J Rheumatol; 2005 Jan; 34(4):269-76. PubMed ID: 16195159
    [Abstract] [Full Text] [Related]

  • 7. Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR.
    Snowden JA, Passweg J, Moore JJ, Milliken S, Cannell P, Van Laar J, Verburg R, Szer J, Taylor K, Joske D, Rule S, Bingham SJ, Emery P, Burt RK, Lowenthal RM, Durez P, McKendry RJ, Pavletic SZ, Espigado I, Jantunen E, Kashyap A, Rabusin M, Brooks P, Bredeson C, Tyndall A.
    J Rheumatol; 2004 Mar; 31(3):482-8. PubMed ID: 14994391
    [Abstract] [Full Text] [Related]

  • 8. Efficient management of rheumatoid arthritis significantly reduces long-term functional disability.
    Tanaka E, Mannalithara A, Inoue E, Hara M, Tomatsu T, Kamatani N, Singh G, Yamanaka H.
    Ann Rheum Dis; 2008 Aug; 67(8):1153-8. PubMed ID: 17971459
    [Abstract] [Full Text] [Related]

  • 9. Outcome in rheumatoid arthritis. A 1985 inception cohort study.
    Suarez-Almazor ME, Soskolne CL, Saunders LD, Russell AS.
    J Rheumatol; 1994 Aug; 21(8):1438-46. PubMed ID: 7983643
    [Abstract] [Full Text] [Related]

  • 10. Chronic comorbidity in patients with early rheumatoid arthritis: a descriptive study.
    Kroot EJ, van Gestel AM, Swinkels HL, Albers MM, van de Putte LB, van Riel PL.
    J Rheumatol; 2001 Jul; 28(7):1511-7. PubMed ID: 11469455
    [Abstract] [Full Text] [Related]

  • 11. The DERAA HLA-DR alleles in patients with early polyarthritis: protection against severe disease and lack of association with rheumatoid arthritis autoantibodies.
    Carrier N, Cossette P, Daniel C, de Brum-Fernandes A, Liang P, Ménard HA, Boire G.
    Arthritis Rheum; 2009 Mar; 60(3):698-707. PubMed ID: 19248090
    [Abstract] [Full Text] [Related]

  • 12. The influence of sex on rheumatoid arthritis: a prospective study of onset and outcome after 2 years.
    Tengstrand B, Ahlmén M, Hafström I.
    J Rheumatol; 2004 Feb; 31(2):214-22. PubMed ID: 14760787
    [Abstract] [Full Text] [Related]

  • 13. Association of concomitant fibromyalgia with worse disease activity score in 28 joints, health assessment questionnaire, and short form 36 scores in patients with rheumatoid arthritis.
    Ranzolin A, Brenol JC, Bredemeier M, Guarienti J, Rizzatti M, Feldman D, Xavier RM.
    Arthritis Rheum; 2009 Jun 15; 61(6):794-800. PubMed ID: 19479706
    [Abstract] [Full Text] [Related]

  • 14. More evidence from a community based series of better outcome in rheumatoid arthritis. Data on the effect of multidisciplinary care on the retention of functional ability.
    Hakala M, Nieminen P, Koivisto O.
    J Rheumatol; 1994 Aug 15; 21(8):1432-7. PubMed ID: 7983642
    [Abstract] [Full Text] [Related]

  • 15. Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor.
    Radstake TR, Sweep FC, Welsing P, Franke B, Vermeulen SH, Geurts-Moespot A, Calandra T, Donn R, van Riel PL.
    Arthritis Rheum; 2005 Oct 15; 52(10):3020-9. PubMed ID: 16200611
    [Abstract] [Full Text] [Related]

  • 16. Long-term course and outcome of functional capacity in rheumatoid arthritis: the effect of disease activity and radiologic damage over time.
    Drossaers-Bakker KW, de Buck M, van Zeben D, Zwinderman AH, Breedveld FC, Hazes JM.
    Arthritis Rheum; 1999 Sep 15; 42(9):1854-60. PubMed ID: 10513799
    [Abstract] [Full Text] [Related]

  • 17. Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor.
    Rioja I, Hughes FJ, Sharp CH, Warnock LC, Montgomery DS, Akil M, Wilson AG, Binks MH, Dickson MC.
    Arthritis Rheum; 2008 Aug 15; 58(8):2257-67. PubMed ID: 18668547
    [Abstract] [Full Text] [Related]

  • 18. What factors influence functional ability in patients with rheumatoid arthritis. Do they alter over time?
    Plant MJ, O'Sullivan MM, Lewis PA, Camilleri JP, Coles EC, Jessop JD.
    Rheumatology (Oxford); 2005 Sep 15; 44(9):1181-5. PubMed ID: 15972357
    [Abstract] [Full Text] [Related]

  • 19. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL, Watson KD, Silman AJ, Symmons DP, British Society for Rheumatology Biologics Register.
    Rheumatology (Oxford); 2006 Dec 15; 45(12):1558-65. PubMed ID: 16705046
    [Abstract] [Full Text] [Related]

  • 20. Adsorptive granulocyte/monocyte apheresis for the treatment of refractory rheumatoid arthritis: an open pilot multicentre trial.
    Sanmartí R, Marsal S, Valverde J, Casado E, Lafuente R, Kashiwagi N, Rodriguez-Cros JR, Erra A, Reina D, Gratacós J.
    Rheumatology (Oxford); 2005 Sep 15; 44(9):1140-4. PubMed ID: 15927997
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.